Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections

14 Jul 2016

Abstract excerpt

Toxoplasma gondii, the most common parasitic infection of human brain and eye, persists across lifetimes, can progressively damage sight, and is currently incurable. New, curative medicines are needed urgently. Herein, we develop novel models to facilitate drug development: EGS strain T. gondii forms cysts in vitro that induce oocysts in cats, the gold standard criterion for cysts. These cysts highly express...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis B Virus Studies
Share to Herpesvirus Infections and Treatments
Share to Toxoplasma gondii Research Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27412848
DOI: 10.1038/srep29179

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infectionsPMID 27412848Read ↗

Structure-based therapeutic development against the Apicomplexan parasitesSemantic proximity Read ↗

Targeted Phenotypic Screening in Plasmodium falciparum and Toxoplasma gondii Reveals Novel Modes of Action of Medicines for Malaria Venture Malaria Box MoleculesSemantic proximity Read ↗

Genetic Evidence for Cytochrome b Q i Site Inhibition by 4(1 H )-Quinolone-3-Diarylethers and Antimycin in Toxoplasma gondiiSemantic proximity Read ↗

Chemotherapeutics for Toxoplasma gondii: Molecular Biotargets, Binding Modes, and Structure–Activity Relationship InvestigationsSemantic proximity Read ↗

Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.Semantic proximity Read ↗

DRUG DISCOVERY AND DEVELOPMENT FOR NEGLECTED TROPICAL DISEASESSemantic proximity Read ↗

Efficacy and mechanism of action of cipargamin as an antibabesial drug candidateSemantic proximity Read ↗

Targeting Channels and Transporters in Protozoan Parasite InfectionsSemantic proximity Read ↗

Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease.Semantic proximity Read ↗

<i>Toxoplasma gondii</i> requires its plant-like heme biosynthesis pathway for infectionSemantic proximity Read ↗

Therapeutics development against the Apicomplexa parasites Plasmodium falciparum and Toxoplasma gondiiSemantic proximity Read ↗

Toxoplasma gondii requires its plant-like heme biosynthesis pathway for infectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.